Genvor Incorporated
GNVR
$1.95
-$0.05-2.50%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -42.10% | -70.16% | 286.07% | -86.63% | 254.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.00% | -63.06% | 282.91% | -84.45% | 283.50% |
| Operating Income | -1.00% | 63.06% | -282.91% | 84.45% | -283.50% |
| Income Before Tax | 33.91% | 61.27% | -270.08% | 85.38% | -179.95% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 33.91% | 61.27% | -270.08% | 85.38% | -179.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.91% | 61.27% | -270.08% | 85.38% | -179.95% |
| EBIT | -1.00% | 63.06% | -282.91% | 84.45% | -283.50% |
| EBITDA | -1.00% | 63.10% | -283.03% | 84.48% | -284.52% |
| EPS Basic | 51.34% | 69.47% | -247.70% | 86.40% | -156.90% |
| Normalized Basic EPS | 49.15% | 68.49% | -256.00% | 83.96% | -180.95% |
| EPS Diluted | 51.34% | 69.47% | -247.70% | 86.40% | -156.90% |
| Normalized Diluted EPS | 49.15% | 68.49% | -256.00% | 83.96% | -180.95% |
| Average Basic Shares Outstanding | 35.85% | 26.62% | 6.43% | 7.78% | 9.29% |
| Average Diluted Shares Outstanding | 35.85% | 26.62% | 6.43% | 7.78% | 9.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |